|
1
|
Nagaiah G, Hossain A, Mooney CJ,
Parmentier J and Remick SC: Anaplastic thyroid cancer: A review of
epidemiology, pathogenesis, and treatment. J Oncol.
2011:5423582011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Davies L and Welch HG: Increasing
incidence of thyroid cancer in the United States, 1973–2002. Jama.
295:2164–2167. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cornett WR, Sharma AK, Day TA, Richardson
MS, Hoda RS, van Heerden JA and Fernandes JK: Anaplastic thyroid
carcinoma: An overview. Curr Oncol Rep. 9:152–158. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
O'Neill JP, O'Neill B, Condron C, Walsh M
and Bouchier-Hayes D: Anaplastic (undifferentiated) thyroid cancer:
Improved insight and therapeutic strategy into a highly aggressive
disease. J Laryngol Otol. 119:585–591. 2005.PubMed/NCBI
|
|
5
|
Paunovic IR, Sipetic SB, Zoric GV, Diklic
AD, Savic DV, Marinkovic J and Zivaljevic VR: Survival and
prognostic factors of anaplastic thyroid carcinoma. Acta Chir Belg.
115:62–72. 2015. View Article : Google Scholar
|
|
6
|
Perri F, Lorenzo GD, Scarpati GD and
Buonerba C: Anaplastic thyroid carcinoma: A comprehensive review of
current and future therapeutic options. World J Clin Oncol.
2:150–157. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kim SH, Kang JG, Kim CS, Ihm SH, Choi MG,
Yoo HJ and Lee SJ: Apigenin induces c-Myc-mediated apoptosis in FRO
anaplastic thyroid carcinoma cells. Mol Cell Endocrinol.
369:130–139. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yu XM, Jaskulasztul R, Ahmed K, Harrison
AD, Kunnimalaiyaan M and Chen H: Resveratrol induces
differentiation markers expression in anaplastic thyroid carcinoma
via activation of Notch1 signaling and suppresses cell growth. Mol
Cancer Ther. 12:1276–1287. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Che H, Guo H, Si X, You Q and Lou W:
Additive effect by combination of Akt inhibitor, MK-2206, and PDGFR
inhibitor, tyrphostin AG 1296, in suppressing anaplastic thyroid
carcinoma cell viability and motility. Onco Ther. 7:425–432.
2014.
|
|
10
|
Reeb AN, Li W, Sewell W, Marlow LA, Tun
HW, Smallridge RC, Copland JA, Spradling K, Chernock R and Lin RY:
S100A8 is a novel therapeutic target for anaplastic thyroid
carcinoma. J Clin Endocrinol Metab. 100:232–242. 2015. View Article : Google Scholar
|
|
11
|
Alonso A, Sasin J, Bottini N, Friedberg I,
Friedberg I, Osterman A, Godzik A, Hunter T, Dixon J and Mustelin
T: Protein tyrosine phosphatases in the human genome. Cell.
117:699–711. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Korbecki J, Baranowska-Bosiacka I,
Gutowska I and Chlubek D: Biochemical and medical importance of
vanadium compounds. Acta Biochim Pol. 59:195–200. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tian X, Fan J, Hou W, Bai S, Ao Q and Tong
H: Sodium orthovanadate induces the apoptosis of SH-SY5Y cells by
inhibiting PIWIL2. Mol Med Rep. 13:874–880. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Klein A, Holko P, Ligeza J and Kordowiak
AM: Sodium orthovanadate affects growth of some human epithelial
cancer cells (A549, HTB44, DU145). Folia Biol (Krakow). 56:115–121.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liu TT, Liu YJ, Wang Q, Yang XG and Wang
K: Reactive- oxygen-species-mediated Cdc25C degradation results in
differential antiproliferative activities of vanadate, tungstate,
and molybdate in the PC-3 human prostate cancer cell line. J Biol
Inorg Chem. 17:311–320. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Günther TM, Kviecinski MR, Baron CC,
Felipe KB, Farias MS, da Silva FO, Bücker NC, Pich CT, Ferreira EA,
Wilhelm Filho D, et al: Sodium orthovanadate associated with
pharmacological doses of ascorbate causes an increased generation
of ROS in tumor cells that inhibits proliferation and triggers
apoptosis. Biochem Biophys Res Commun. 430:883–888. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wu Y, Ma Y, Xu Z, Wang D, Zhao B, Pan H,
Wang J, Xu D, Zhao X, Pan S, et al: Sodium orthovanadate inhibits
growth of human hepatocellular carcinoma cells in vitro and in an
orthotopic model in vivo. Cancer Lett. 351:108–116. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kordowiak AM, Klein A, Goc A and Dabroś W:
Comparison of the effect of VOSO4, Na3VO4 and NaVO3 on
proliferation, viability and morphology of H35-19 rat hepatoma cell
line. Pol J Pathol. 58:51–57. 2007.PubMed/NCBI
|
|
19
|
Reed LJ and Muench H: A simple method of
estimating fifty percent endpoints. Am J Hyg. 27:1938.
|
|
20
|
Ostrowski J, Woszczyński M, Kowalczyk P,
Trzeciak L, Hennig E and Bomsztyk K: Treatment of mice with EGF and
orthovanadate activates cytoplasmic and nuclear MAPK, p70S6k, and
p90rsk in the liver. J Hepatol. 32:965–974. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Choi YJ, Lim SY, Woo JH, Kim YH, Kwon YK,
Suh SI, Lee SH, Choi WY, Kim JG, Lee IS, et al: Sodium
orthovanadate potentiates EGCG-induced apoptosis that is dependent
on the ERK pathway. Biochem Biophys Res Commun. 305:176–185. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Afshari CA, Kodama S, Bivins HM, Willard
TB, Fujiki H and Barrett JC: Induction of neoplastic progression in
Syrian hamster embryo cells treated with protein phosphatase
inhibitors. Cancer Res. 53:1777–1782. 1993.PubMed/NCBI
|
|
23
|
Hwang JT, Lee M, Jung SN, Lee HJ, Kang I,
Kim SS and Ha J: AMP-activated protein kinase activity is required
for vanadate-induced hypoxia-inducible factor 1alpha expression in
DU145 cells. Carcinogenesis. 25:24972004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang Z, Huang C, Li J and Shi X:
Vanadate-induced cell growth arrest is p53-dependent through
activation of p21 in C141 cells. J Inorg Biochem. 89:142–148. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Morita A, Zhu J, Suzuki N, Enomoto A,
Matsumoto Y, Tomita M, Suzuki T, Ohtomo K and Hosoi Y: Sodium
orthovanadate suppresses DNA damage-induced caspase activation and
apoptosis by inactivating p53. Cell Death Differ. 13:499–511. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Gamero AM and Larner AC: Vanadate
facilitates interferon alpha-mediated apoptosis that is dependent
on the Jak/Stat pathway. J Bioll Chem. 276:13547–13553. 2001.
View Article : Google Scholar
|
|
27
|
Stewart C, Mihai R and Holly JM: Increased
tyrosine kinase activity but not calcium mobilization is required
for ceramide-induced apoptosis. Exp Cell Res. 250:329–338. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Guo YL, Baysal K, Kang B, Yang LJ and
Williamson JR: Correlation between sustained c-Jun N-terminal
protein Kinase activation and apoptosis induced by tumor necrosis
factor-α in rat mesangial cells. J Biol Chem. 273:4027–4034. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Figiel I and Kaczmarek L: Orthovanadate
induces cell death in rat dentate gyrus primary culture.
Neuroreport. 8:2465–2470. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Morita A, Yamamoto S, Wang B, Tanaka K,
Suzuki N, Aoki S, Ito A, Nanao T, Ohya S, Yoshino M, et al: Sodium
orthovanadate inhibits p53-mediated apoptosis. Cancer Res.
70:257–265. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Cossarizza A, Franceschi C, Monti D,
Salvioli S, Bellesia E, Rivabene R, Biondo L, Rainaldi G, Tinari A
and Malorni W: Protective effect of N-acetylcysteine in tumor
necrosis factor-alpha-induced apoptosis in U937 cells: The role of
mitochondria. Exp Cell Res. 220:232–240. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ray RS, Ghosh B, Rana A and Chatterjee M:
Suppression of cell proliferation, induction of apoptosis and cell
cycle arrest: Chemopreventive activity of vanadium in vivo and in
vitro. Int J Cancer. 120:13–23. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kanna P, Mahendrakumar CB, Chakraborty T,
Hemalatha P, Banerjee P and Chatterjee M: Effect of vanadium on
colonic aberrant crypt loci induced in rats by 1,2 dimethyl
hydrazine. World J Gastroenterol. 9:1020–1027. 2003. View Article : Google Scholar : PubMed/NCBI
|
